Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#4544 Spatial and temporal intratumour heterogeneity of pancreatic neuroendocrine tumours (PanNET)
Introduction: Data derived from the study of intertumour heterogeneity have led to propose that PanNET evolution may start either from beta cells with good prognosis, or from alpha cells with sequential alterations of MDA (MENIN-DAXX/ATRX) leading to more aggressive lesions.
Conference:
Presenting Author: Awan Z
Authors: Awan Z, Bourdeleau P, Epée J, Ps H, Tihy M,
Keywords: Pancreatic neuroendocrine tumour, Heterogeneity, Tumour microenvironment,
Introduction: High-grade pancreatic neuroendocrine carcinoma (panNEC) pose challenges in terms of classification and treatment. While molecular genetics have made strides in deciphering significant inter-tumor heterogeneity, the extent of intra-tumoral heterogeneity and lineage plasticity remains unexplored.
Conference:
Presenting Author:
Authors: Debnath O, Detjen K, Berger H, Kirchner P, Marinoni I,
Keywords: PanNEC, Single cell RNAseq,
Introduction: The study of small intestine neuroendocrine neoplasms (siNENs) transcriptomics represents a challenge due to their rarity, tissue availability, and heterogeneity. Recent studies identified different molecular subtypes, but there are still gaps in the molecular mechanisms driving siNEN progression.
Conference:
Presenting Author:
Authors: Ibáñez-Costa A, Pedraza-Arevalo S, Moreno-Montilla M, Hernando J, García A,
Keywords: small intestine neuroendocrine neoplasm, splicing, transcriptomics, biomarker,
Introduction: Pancreatic Neuroendocrine Neoplasms (PanNENs) are a major component the Multiple Endocrine Neoplasia 1 Syndrome (MEN1). Although multiple pancreatic neuroendocrine microtumors (microadenomatosis) are a histomorphological hallmark of MEN1, their molecular status compared to PanNET as well as their metastasis remains unclear.
Conference:
Presenting Author:
Authors: Chouchane A, Kirchner P, Sylvain Maire R, Schiavo Lena M, Falconi M,
Keywords: Microtumor, MEN1, PanNETs, RNAseq, Transcriptomics, Progression,
Introduction: It is unknown whether tumor infiltrating lymphocytes (TILs) from NETs may be an effective treatment in patients with NETs.
Conference:
Presenting Author: Chaoul N
Authors: Chaoul N, d'Angelo G, Giglio A, Mandriani B, Matrella M,
Keywords: panNET, TILs, adoptive T cell therapy, neoantigen-reactive TILs,